10x Genomics Inc Ordinary Shares - Class A (TXG)
Industry Health Information Services
This stock can be held in an Investment ISA and an Investment Account
Sell
$9.20
Buy
$9.21
$0.08 (+0.88%)
Prices updated at 15 May 2025, 21:12 EDT
| Prices minimum 15 mins delay
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
---|---|---|
619m | 611m | |
409m | 414m | |
-204m | -195m | |
-33.03 | -31.85 | |
-255m | -183m | |
-205m | -134m | |
Sales, General and administrative | 343m | 344m |
Interest expenses | 33,000 | 4,000 |
Provision for income taxes | 6m | 5m |
Operating expenses | 614m | 609m |
Income before taxes | -249m | -178m |
Net income available to common shareholders | -255m | -183m |
-2.18 | -1.52 | |
Net interest income | 17m | 18m |
Advertising and promotion | - | - |
Net investment income, net | - | - |
Realised capital gains (losses), net | - | - |
Total benefits, claims and expenses | - | - |
Earnings per share (diluted) | -2.18 | -1.52 |
Free cash flow per share | -0.9727 | 0.2092 |
Book value/share | 6.2573 | 5.9105 |
Debt equity ratio | 0.11315 | 0.103258 |
Balance sheet
Year | 2023 | 2024 |
---|---|---|
Current assets | 596m | 584m |
Current liabilities | 127m | 118m |
Total capital | 741m | 710m |
Total debt | 95m | 83m |
Total equity | 741m | 710m |
Total non current liabilities | - | - |
Loans | - | - |
Total assets | 965m | 919m |
Total liabilities | - | - |
Cash and cash equivalents | 359m | 344m |
Common stock | 119m | 122m |
Cash flow
Year | 2023 | 2024 |
---|---|---|
Cash at beginning of period | 227m | 359m |
Cash dividends paid | - | - |
-65m | -7m | |
Investments (gains) losses | 133m | -33m |
359m | 344m | |
Net income | - | - |
-15m | 7m | |
-50m | -13m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.